Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations

Journal of Rheumatology

Volumn 27, Issue 1, 2000, Pages 135-141

  Galeazzi, Mauro ^a   Annunziata, Pasquale ^a   Sebastlani, Gian Domenico ^a,b   Bellisai, Francesca ^a   Campanella, Valeria ^a   Ferrara, Gian Battista ^a,c   Font, Josep ^a,d   Houssiau, Frederic ^a,e   Passiu, Giuseppe ^a   De Ramon Garrido, Enrique ^a,f   Fernandez Nebro, Antonio ^a,g   Bracci, Luisa ^a   Scorza, Raffaella ^a,h   Puddu, Pietro ^a,i   Jedryka Goral, Anna ^a,j   Smolen, Josef ^a,k   Tincani, Angela ^a   Carcassi, Carlo ^a   Morozzi, Gabriella ^a   Marcolongo, Roberto ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^f UNIVERSITY OF MÁLAGA   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^j UNIVERSITY OF WARSAW   (Poland)

^k GENERAL HOSPITAL LINZ   (Austria)

more..

Author keywords

Anti GM1; HLA; Neuropsychiatric manifestations; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; DNA ANTIBODY; DOUBLE STRANDED DNA; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; HLA ANTIGEN CLASS 2; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL FEATURE; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOME; HLA SYSTEM; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIGRAINE; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOSIS; SEROLOGY; SEROTYPING; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; COHORT STUDIES; EUROPE; FEMALE; GANGLIOSIDES; GENES, MHC CLASS II; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES;

EID: 0033955159     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine 1968;47:337-69.
2. Abel T, Gladman DD, Urowitz MB. Neuropsychiatric lupus. J Rheumatol 1980;7:325-33.
3. Adelman DC, Saltiel E, Klinenberg JR. The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum 1986;15:185-99.
4. Bluestein HG. Neuropsychiatric manifestations of systemic lupus erythematosus. N Engl J Med 1987;317:309-11.
5. Wilson HA, Winfield JB, Lahita RG, Koffler D. Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum 1979;22:458-62.
6. Zvaifler NJ, Bluestein HG. The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1982;25:862-6.
7. Hanly JG, Walsh NM, Fisk JD, et al. Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br J Rheumatol 1993;32:291-6.
8. Winfield JB, Brunner CM, Koffler D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum 1978;21:289-94.
9. Bresnihan B, Oliver M, Williams B, Hughes GRV. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum 1979;22:313-20.
10. How A. Dent PB. Liao SK, Denburg JA. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1985;28:789-95.
11. Bluestein HG. Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1978;75:3965-9.
12. Denburg JA, Behmann SA. Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kd reactivity. Ann Rheum Dis 1994; 53:304-8.
13. Isshi K, Hirohata S. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1996;39:1483-90.
14. Harris EN, Pierangeli S. Antiphospholipid antibodies and cerebral lupus. Ann NY Acad Sci 1997;14:270-8.
15. Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 1997;3:377-86.
16. Costallat LTL, de Oliveira RM, Santiago MB, Cossermelli W, Samara AM. Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies. Clin Rheumatol 1990;9:489-97.
17. Hirano T, Hashimoto H, Shiokawa Y, et al. Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J Clin Invest 1980;66:1437-40.
18. Sindern E, Stark E, Haas J, Steck AJ. Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy. Acta Neurol Scand 1991;83:399-402.
19. Ledeen RW. Gangliosides of the neuron. Trends Neurosci 1985;8:169-74
20. Galeazzi M, Sebastiani GD, Veronesi M, Morozzi G, Marcolongo R. Genetic aspects of systemic lupus erythematosus. In: Boki KA, Drosos AA, Moutsopoulos HM, Tzioufas AG, Vlachoyiannopoulos PG, editors. Proceedings from VII Mediterranean Congress of Rheumatology, Athens, Greece, 1994; Bologna: Monduzzi Editore: 11-5.
21. Schur P. Genetics of systemic lupus erythematosus. Lupus 1995;4:425-37.
22. Sebastiani GD, Galeazzi M, Morozzi G, Marcolongo R. The immunogenetics of the antiphospholipid syndrome, anticardiolipin antibodies, and lupus anticoagulant. Semin Arthritis Rheum 1996;25:414-20.
23. Sebastiani GD, Lulli P, Passiu G, et al. Anticardiolipin antibodies: their relationship with HLA-DR antigens in systemic lupus erythematosus. Br J Rheumatol 1991;30:156-7.
24. Lulli P, Sebastiani GD, Trabace S, et al. HLA antigens in Italian patients with systemic lupus erythematosus: evidence for the association of Dqw2 with the autoantibody response to extractable nuclear antigens. Clin Exp Rheumatol 1991;9:475-9.
25. Sebastiani GD, Galeazzi M, Passiu G, et al. Genetics of antiendothelial cell antibodies in systemic lupus erythematosus: the role of HLA-DP alleles. Contrib Nephrol 1992;99:102-6.
26. Galeazzi M, Sebastiani GD, Passiu G, et al. HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. J Rheumatol 1992;19:42-6.
27. The ARA Subcommittee for SLE Criteria. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982;25:1271-7.
28. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine 1993;72:113-24.
29. Hanly JG. CNS lupus. Cognitive impairment. In: Klippel JH. Dieppe PA, editors. Rheumatology. London: Mosby; 1998; 7.8.10-7.8.11.
30. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1988;97:12-3.
31. Galeazzi M, Morozzi G, Sebastiani GD, et al. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. Clin Exp Rheumatol 1998;16:541-6.
32. Sadiq A, Thomas FP, Kilidireas K, et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 1990;40:1067-72.
33. Simone I, Annunziata P, Maimone D. Liguori L, Leante R, Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1993;114:49-55.
34. Annunziata P, Maimone D. Guazzi GC. Association of polyclonal anti-GM1 IgM and anti-neurofilament antibodies with CSF oligoclonal bands in a young with amyotrophic lateral sclerosis. Acta Neurol Scand 1995;92:387-93.
35. Gharavi AE, Harris EN, Asherson RA. Hughes GRV. Antiphospholipid antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
36. 2GP1 in rat: isolation from serum and demonstration in lipoprotein density fraction. J Biochem 1980; 11:265-70.
37. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: beta2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
38. La Rosa L, Meroni PL, Tincani A, Balestrieri G, Faden D, Lojacono A. Beta 2 glycoprotein I and placental anticoagulant protein 1 in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994;21:1684-93.
39. Kimura A, Sasazuki T. HLA 1991. Eleventh International Histocompatibility Workshop reference protocol for HLA-typing technique. In: Tsuji K, Aizawa M, Sasasuki T, editors. Oxford: Oxford University Press; 1992;397-419.
40. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1955;20:309-11.
41. Petronsk A. Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 1991;14:927-36.
42. Ledeen RW. Ganglioside structure and distribution: are they localized at the nerve ending? J Supramol Struct 1978;8:1-17.
43. Adams D, Kuntzer T, Burger D. et al. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 1991;32:223-30.
44. Yoshio T, Masuyama J, Ikeda M, et al. Quantitation of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus. J Rheumatol 1995;22:1681-7.
45. Endo T, Scott DD, Stewart SS, Kundu SK, Marcus DM. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol 1984;132:1793-7.
46. Liang MH, et al for the ACR Ad Hoc Committee on NP-lupus nomenclature. The ACR nomenclature and reporting standards for neuropsychiatric systemic lupus erythematosus syndromes [abstract]. Lupus 1998;7:100.
47. Russo R, Gilday D, Laxer RM, Eddy A, Silverman ED. Single photon emission computed tomography scanning in childhood systemic lupus erythematosus. J Rheumatol 1998;25:576-82.
48. Jara LJ, Irigoyen L, Ortiz M de J, Zazueta B, Bravo G. Espinoza LR. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 1998;17:110-4.
49. Savi M, Ferraccioli GF, Neri TM, et al. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus. Arthritis Rheum 1988;31:1568-70.
50. Smolen JS, Klippel JH, Penner E, et al. HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis 1987;46:457-62.